Hypothesis: Performance of sentinel node biopsy (SNB) instead of full axill
ary lymph node dissection (ALND) by inexperienced surgeons will lead to und
erstaging of some women with breast cancer and increased costs.
Design: A decision analysis model was used to investigate the implications
of SNB vs full ALND during the learning phase (60-80 procedures). This mode
l simulates a randomized trial of 10 000 women in each arm. Data regarding
the learning curve were obtained from published series.
Main Outcome Measures: Percentage of women with inaccurate staging of their
breast cancer, overall survival, quality-adjusted survival, and potential
costs of SNB vs ALND.
Results: Performance of SNB instead of ALND results in inability to locate
a sentinel. node in 38% of attempts during the learning phase (compared wit
h 10% in later cases) and understaging in 12% of patients during the learni
ng phase (compared with 0% in later cases). This understaging is associated
with a small decrement. in survival (1%-2%) and an increased risk of axill
ary recurrence. Sentinel node biopsy is cost-effective only when the abilit
y to detect sentinel nodes exceeds 80%; and the cost of SNB is less than 50
% of the cost of ALND.
Conclusions: To ensure accurate staging of patients with breast cancer, all
surgeons should perform full ALND while learning SNB techniques. Only afte
r documentation of accuracy of SNB (sensitivity >90%) should full ALND be o
mitted for women with negative sentinel nodes.